{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:10:47Z","timestamp":1790093447226,"version":"4.0.1"},"reference-count":61,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Recanalization with restored cerebral perfusion is the primary goal of thrombolytic therapy in acute ischemic stroke. The identification of adjunctive therapies that can be safely used to enhance thrombolysis in stroke remains an elusive goal. We report here the development of a mouse in situ carotid artery thrombolysis (iCAT) stroke model involving graded cerebral ischemia to induce unihemispheric infarction after thrombotic occlusion of the common carotid artery (CCA). Electrolytic-induced thrombotic occlusion of the left CCA enabled real-time assessment of recanalization and rethrombosis events after thrombolysis with recombinant tissue-type plasminogen activator (rtPA). Concurrent transient stenosis of the right CCA induced unihemispheric hypoperfusion and infarction in the left middle cerebral artery territory. Real-time assessment of thrombolysis revealed recanalization rates &amp;lt;30% in rtPA-treated animals with high rates of rethrombosis. Addition of the direct thrombin inhibitor argatroban increased recanalization rates to 50% and reduced rethrombosis. Paradoxically, this was associated with increased cerebral ischemia and stroke-related mortality (25%-42%). Serial analysis of carotid and cerebral blood flow showed that coadministration of argatroban with rtPA resulted in a marked increase in carotid artery embolization, leading to distal obstruction of the middle cerebral artery. Real-time imaging of carotid thrombi revealed that adjunctive anticoagulation destabilized platelet-rich thrombi at the vessel wall, leading to dislodgement of large platelet emboli. These studies confirm the benefits of anticoagulants in enhancing thrombolysis and large artery recanalization; however, at high levels of anticoagulation (\u223c3-fold prolongation of activated partial thromboplastin time), this effect is offset by increased incidence of carotid artery embolization and distal middle cerebral artery occlusion. The iCAT stroke model should provide important new insight into the effects of adjunctive antithrombotic agents on real-time thrombus dynamics during thrombolysis and their correlation with stroke outcomes.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021006008","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T19:33:35Z","timestamp":1656531215000},"page":"5449-5462","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["Development of a carotid artery thrombolysis stroke model in mice"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7872-9673","authenticated-orcid":false,"given":"Jessica A. A.","family":"Maclean","sequence":"first","affiliation":[{"name":"1Heart Research Institute, Newtown, NSW, Australia;"},{"name":"2Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia J.","family":"Tomkins","sequence":"additional","affiliation":[{"name":"1Heart Research Institute, Newtown, NSW, Australia;"},{"name":"2Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-8972","authenticated-orcid":false,"given":"Sharelle A.","family":"Sturgeon","sequence":"additional","affiliation":[{"name":"1Heart Research Institute, Newtown, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-3136","authenticated-orcid":false,"given":"Benjamin R.","family":"Hofma","sequence":"additional","affiliation":[{"name":"1Heart Research Institute, Newtown, NSW, Australia;"},{"name":"2Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5459-9093","authenticated-orcid":false,"given":"Imala","family":"Alwis","sequence":"additional","affiliation":[{"name":"1Heart Research Institute, Newtown, NSW, Australia;"},{"name":"2Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0637-2716","authenticated-orcid":false,"given":"Andre L.","family":"Samson","sequence":"additional","affiliation":[{"name":"1Heart Research Institute, Newtown, NSW, Australia;"},{"name":"2Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-5840","authenticated-orcid":false,"given":"Simone M.","family":"Schoenwaelder","sequence":"additional","affiliation":[{"name":"1Heart Research Institute, Newtown, NSW, Australia;"},{"name":"2Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-1991","authenticated-orcid":false,"given":"Shaun P.","family":"Jackson","sequence":"additional","affiliation":[{"name":"1Heart Research Institute, Newtown, NSW, Australia;"},{"name":"2Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; and"},{"name":"3Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"issue":"3","key":"2022092315285995700_B1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.STR.0000258112.14918.24","article-title":"The impact of recanalization on ischemic stroke outcome: a meta-analysis","volume":"38","author":"Rha","year":"2007","journal-title":"Stroke."},{"issue":"24","key":"2022092315285995700_B2","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med."},{"issue":"6","key":"2022092315285995700_B3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1212\/WNL.59.6.862","article-title":"Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator","volume":"59","author":"Alexandrov","year":"2002","journal-title":"Neurology."},{"issue":"7","key":"2022092315285995700_B4","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/01.STR.0000170711.43405.81","article-title":"Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke","volume":"36","author":"Rubiera","year":"2005","journal-title":"Stroke."},{"issue":"3","key":"2022092315285995700_B5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.STR.0000257304.21967.ba","article-title":"Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke","volume":"38","author":"Saqqur","year":"2007","journal-title":"Stroke."},{"issue":"2","key":"2022092315285995700_B6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00129784-200404020-00004","article-title":"Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction","volume":"4","author":"French","year":"2004","journal-title":"Am J Cardiovasc Drugs."},{"issue":"7","key":"2022092315285995700_B7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/clc.4960210715","article-title":"Restoration of coronary blood flow by single bolus injection of the GPIIb\/IIIa receptor antagonist c7E3 Fab in a patient with acute myocardial infarction of recent onset","volume":"21","author":"Domanovits","year":"1998","journal-title":"Clin Cardiol."},{"issue":"5","key":"2022092315285995700_B8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.amjcard.2004.10.038","article-title":"Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb\/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)","volume":"95","author":"Rebeiz","year":"2005","journal-title":"Am J Cardiol."},{"issue":"3","key":"2022092315285995700_B9","first-page":"CD005208","article-title":"Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke","author":"Ciccone","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"issue":"10","key":"2022092315285995700_B10","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1161\/STROKEAHA.114.006268","article-title":"Early deterioration after thrombolysis plus aspirin in acute stroke: a post hoc analysis of the Antiplatelet Therapy in Combination with Recombinant t-PA Thrombolysis in Ischemic Stroke trial","volume":"45","author":"Zinkstok","year":"2014","journal-title":"Stroke."},{"issue":"6","key":"2022092315285995700_B11","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/STROKEAHA.117.016720","article-title":"Randomized, multicenter trial of ARTSS-2 (Argatroban with recombinant tissue plasminogen activator for acute stroke)","volume":"48","author":"Barreto","year":"2017","journal-title":"Stroke."},{"issue":"11","key":"2022092315285995700_B12","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/hs1101.097390","article-title":"Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke","volume":"32","author":"Morris","year":"2001","journal-title":"Stroke."},{"issue":"2","key":"2022092315285995700_B13","first-page":"780","article-title":"Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model","volume":"278","author":"Kawai","year":"1996","journal-title":"J Pharmacol Exp Ther."},{"issue":"6","key":"2022092315285995700_B14","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1161\/01.RES.67.6.1552","article-title":"In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator","volume":"67","author":"Jang","year":"1990","journal-title":"Circ Res."},{"issue":"4","key":"2022092315285995700_B15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12975-013-0315-9","article-title":"Characterization of a new model of thromboembolic stroke in C57 black\/6J mice","volume":"5","author":"Ansar","year":"2014","journal-title":"Transl Stroke Res."},{"issue":"10","key":"2022092315285995700_B16","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1161\/STROKEAHA.107.487520","article-title":"Mouse model of in situ thromboembolic stroke and reperfusion","volume":"38","author":"Orset","year":"2007","journal-title":"Stroke."},{"issue":"2","key":"2022092315285995700_B17","doi-asserted-by":"crossref","first-page":"e0148503","DOI":"10.1371\/journal.pone.0148503","article-title":"A comparative study of variables influencing ischemic injury in the Longa and Koizumi methods of intraluminal filament middle cerebral artery occlusion in mice","volume":"11","author":"Morris","year":"2016","journal-title":"PLoS One."},{"issue":"10","key":"2022092315285995700_B18","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/00004647-199710000-00010","article-title":"A mouse model of embolic focal cerebral ischemia","volume":"17","author":"Zhang","year":"1997","journal-title":"J Cereb Blood Flow Metab."},{"issue":"1","key":"2022092315285995700_B19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13231-014-0014-y","article-title":"Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke","volume":"7","author":"Tomkins","year":"2015","journal-title":"Exp Transl Stroke Med."},{"issue":"9","key":"2022092315285995700_B20","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/01.STR.0000137412.35700.0e","article-title":"Mouse model of microembolic stroke and reperfusion","volume":"35","author":"Atochin","year":"2004","journal-title":"Stroke."},{"issue":"2","key":"2022092315285995700_B21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jneumeth.2012.09.006","article-title":"Embolic middle cerebral artery occlusion model using thrombin and fibrinogen composed clots in rat","volume":"211","author":"Ren","year":"2012","journal-title":"J Neurosci Methods."},{"issue":"76","key":"2022092315285995700_B22","first-page":"e50370","article-title":"Photothrombotic ischemia: a minimally invasive and reproducible photochemical cortical lesion model for mouse stroke studies","volume":"76","author":"Labat-gest","year":"2013","journal-title":"J Vis Exp."},{"key":"2022092315285995700_B23","doi-asserted-by":"crossref","first-page":"112418","DOI":"10.1016\/j.bbr.2019.112418","article-title":"Motor deficit in the mouse ferric chloride-induced distal middle cerebral artery occlusion model of stroke","volume":"380","author":"Syeara","year":"2020","journal-title":"Behav Brain Res."},{"issue":"2","key":"2022092315285995700_B24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00401-017-1667-0","article-title":"Ischemic stroke: experimental models and reality","volume":"133","author":"Sommer","year":"2017","journal-title":"Acta Neuropathol."},{"key":"2022092315285995700_B25","volume-title":"National Health and Medical Research Council. Australian Code for the Care and Use of Animals for Scientific Purposes","year":"2013","edition":"8th ed."},{"issue":"1","key":"2022092315285995700_B26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vascn.2005.06.006","article-title":"Adaptation of the Folts and electrolytic methods of arterial thrombosis for the study of anti-thrombotic molecules in small animals","volume":"53","author":"Sturgeon","year":"2006","journal-title":"J Pharmacol Toxicol Methods."},{"issue":"11","key":"2022092315285995700_B27","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1182\/blood-2005-10-4244","article-title":"Thrombin overcomes the thrombosis defect associated with platelet GPVI\/FcRgamma deficiency","volume":"107","author":"Mangin","year":"2006","journal-title":"Blood."},{"issue":"1","key":"2022092315285995700_B28","doi-asserted-by":"crossref","first-page":"12862","DOI":"10.1038\/ncomms12862","article-title":"14-3-3\u03b6 regulates the mitochondrial respiratory reserve linked to platelet phosphatidylserine exposure and procoagulant function","volume":"7","author":"Schoenwaelder","year":"2016","journal-title":"Nat Commun."},{"issue":"2","key":"2022092315285995700_B29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/1056-8719(96)00006-8","article-title":"A highly reproducible model of arterial thrombosis in rats","volume":"35","author":"Guarini","year":"1996","journal-title":"J Pharmacol Toxicol Methods."},{"issue":"12","key":"2022092315285995700_B30","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1538-7836.2008.03174.x","article-title":"Low molecular weight contaminants in commercial preparations of plasmin and t-PA activate neurons","volume":"6","author":"Samson","year":"2008","journal-title":"J Thromb Haemost."},{"issue":"6","key":"2022092315285995700_B31","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1182\/blood-2003-10-3401","article-title":"Antibody blockade or mutation of the fibrinogen gamma-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen","volume":"103","author":"Jirouskov\u00e1","year":"2004","journal-title":"Blood."},{"issue":"1","key":"2022092315285995700_B32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00000637-199701000-00011","article-title":"A technique to investigate mural thrombus formation in small arteries and veins: I. Comparative morphometric and histological analysis","volume":"38","author":"Stockmans","year":"1997","journal-title":"Ann Plast Surg."},{"issue":"6","key":"2022092315285995700_B33","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/01.STR.0000126118.44249.5c","article-title":"Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us?","volume":"35","author":"Krieger","year":"2004","journal-title":"Stroke."},{"issue":"7","key":"2022092315285995700_B34","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/jcbfm.2013.51","article-title":"Early identification of potentially salvageable tissue with MRI-based predictive algorithms after experimental ischemic stroke","volume":"33","author":"Bouts","year":"2013","journal-title":"J Cereb Blood Flow Metab."},{"issue":"6","key":"2022092315285995700_B35","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1161\/STROKEAHA.114.007964","article-title":"Reperfusion within 6 hours outperforms recanalization in predicting penumbra salvage, lesion growth, final infarct, and clinical outcome","volume":"46","author":"Cho","year":"2015","journal-title":"Stroke."},{"issue":"6","key":"2022092315285995700_B36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/01.CIR.97.6.544","article-title":"Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors","volume":"97","author":"Weitz","year":"1998","journal-title":"Circulation."},{"issue":"3","key":"2022092315285995700_B37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/01.CIR.82.3.930","article-title":"Thrombolytic activity of a novel plasminogen activator, LY210825, compared with recombinant tissue-type plasminogen activator in a canine model of coronary artery thrombosis","volume":"82","author":"Jackson","year":"1990","journal-title":"Circulation."},{"issue":"3","key":"2022092315285995700_B38","doi-asserted-by":"crossref","first-page":"H959","DOI":"10.1152\/ajpheart.00649.2005","article-title":"Effect of thrombolysis on myocardial injury: recombinant tissue plasminogen activator vs. alfimeprase","volume":"290","author":"Hong","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"Pt B","key":"2022092315285995700_B39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2017.09.022","article-title":"Animal models of ischaemic stroke and characterisation of the ischaemic penumbra","volume":"134","author":"McCabe","year":"2018","journal-title":"Neuropharmacology."},{"issue":"24","key":"2022092315285995700_B40","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1161\/01.CIR.103.24.2897","article-title":"Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement","volume":"103","author":"Alexandrov","year":"2001","journal-title":"Circulation."},{"issue":"1","key":"2022092315285995700_B41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.STR.0000251800.01964.f6","article-title":"Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study","volume":"38","author":"Saqqur","year":"2007","journal-title":"Stroke."},{"issue":"5","key":"2022092315285995700_B42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000362435","article-title":"Instant reocclusion following mechanical thrombectomy of in situ thromboocclusion and the role of low-dose intra-arterial tirofiban","volume":"37","author":"Kang","year":"2014","journal-title":"Cerebrovasc Dis."},{"issue":"11","key":"2022092315285995700_B43","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1161\/STROKEAHA.118.021685","article-title":"Predictors of unexpected early reocclusion after successful mechanical thrombectomy in acute ischemic stroke patients","volume":"49","author":"Mosimann","year":"2018","journal-title":"Stroke."},{"issue":"11","key":"2022092315285995700_B44","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1161\/STROKEAHA.118.022327","article-title":"Outcomes of endovascular treatment for acute intracranial atherosclerosis-related large vessel occlusion","volume":"49","author":"Baek","year":"2018","journal-title":"Stroke."},{"issue":"1","key":"2022092315285995700_B45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nat Rev Dis Primers."},{"issue":"18","key":"2022092315285995700_B46","doi-asserted-by":"crossref","first-page":"18434","DOI":"10.1074\/jbc.M401431200","article-title":"Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4","volume":"279","author":"Quinton","year":"2004","journal-title":"J Biol Chem."},{"issue":"7329","key":"2022092315285995700_B47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"BMJ."},{"issue":"5","key":"2022092315285995700_B48","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0735-1097(00)00554-4","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade in coronary artery disease","volume":"35","author":"Lincoff","year":"2000","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"2022092315285995700_B49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00129784-200404010-00004","article-title":"Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: acute coronary syndromes and elective stenting","volume":"4","author":"Granada","year":"2004","journal-title":"Am J Cardiovasc Drugs."},{"key":"2022092315285995700_B50","doi-asserted-by":"crossref","first-page":"245037","DOI":"10.1155\/2012\/245037","article-title":"Clinical use of aspirin in treatment and prevention of cardiovascular disease","volume":"2012","author":"Dai","year":"2012","journal-title":"Thrombosis."},{"issue":"18","key":"2022092315285995700_B51","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1053\/euhj.2002.3160","article-title":"Platelet glycoprotein IIb\/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy","volume":"23","author":"Roffi","year":"2002","journal-title":"Eur Heart J."},{"issue":"2","key":"2022092315285995700_B52","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V72.2.616.616","article-title":"Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity","volume":"72","author":"Owen","year":"1988","journal-title":"Blood."},{"issue":"7","key":"2022092315285995700_B53","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0735-1097(99)00107-2","article-title":"A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study","volume":"33","author":"Jang","year":"1999","journal-title":"J Am Coll Cardiol."},{"key":"2022092315285995700_B54","doi-asserted-by":"crossref","first-page":"bcr2013202054","DOI":"10.1136\/bcr-2013-202054","article-title":"An uncommon complication of acute stroke thrombolysis","volume":"2014","author":"Allan","year":"2014","journal-title":"BMJ Case Rep."},{"issue":"1","key":"2022092315285995700_B55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jon200010127","article-title":"Intracranial clot dissolution is associated with embolic signals on transcranial Doppler","volume":"10","author":"Alexandrov","year":"2000","journal-title":"J Neuroimaging."},{"issue":"3","key":"2022092315285995700_B56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11239-013-0899-7","article-title":"Assessing bleeding risk in patients taking anticoagulants","volume":"35","author":"Shoeb","year":"2013","journal-title":"J Thromb Thrombolysis."},{"issue":"2","key":"2022092315285995700_B57","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/STROKEAHA.111.617902","article-title":"Adjunctive and alternative approaches to current reperfusion therapy","volume":"43","author":"Barreto","year":"2012","journal-title":"Stroke."},{"key":"2022092315285995700_B58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/VHRM.S88088","article-title":"Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era","volume":"12","author":"Toth","year":"2016","journal-title":"Vasc Health Risk Manag."},{"issue":"2","key":"2022092315285995700_B59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40119-020-00197-0","article-title":"Dual antiplatelet therapy in coronary artery disease","volume":"9","author":"Sharma","year":"2020","journal-title":"Cardiol Ther."},{"issue":"21","key":"2022092315285995700_B60","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood-2013-12-543074","article-title":"GpIb\u03b1-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice","volume":"123","author":"Le Behot","year":"2014","journal-title":"Blood."},{"issue":"1","key":"2022092315285995700_B61","doi-asserted-by":"crossref","first-page":"16171","DOI":"10.1038\/srep16171","article-title":"MouseMove: an open source program for semi-automated analysis of movement and cognitive testing in rodents","volume":"5","author":"Samson","year":"2015","journal-title":"Sci Rep."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/18\/5449\/1922220\/advancesadv2021006008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/18\/5449\/1922220\/advancesadv2021006008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T15:32:08Z","timestamp":1663947128000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/18\/5449\/485723\/Development-of-a-carotid-artery-thrombolysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":61,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,9,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006008","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}